Document Detail


Evaluation of the Sensitivity and Specificity of 11C-Metomidate Positron Emission Tomography (PET)-CT for Lateralizing Aldosterone Secretion by Conn's Adenomas.
MedLine Citation:
PMID:  22112805     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Context:Identification of unilateral aldosterone-producing (Conn's) adenomas has traditionally required lateralization by the invasive and technically difficult procedure of adrenal vein sampling (AVS). (11)C-metomidate, a potent inhibitor of adrenal steroidogenic enzymes, is a positron emission tomography (PET) radiotracer that is selectively accumulated by Conn's adenomas.Objective:The objective of the study was to compare the sensitivity and specificity of (11)C-metomidate PET-computed tomography (CT) against the current gold standard of AVS.Design:The design of the study was within-patient comparison of diagnostic techniques.Setting:The study was conducted at a single center-university teaching hospital.Patients:Thirty-nine patients with primary hyperaldosteronism (PHA) and five with nonfunctioning adenomas (incidentalomas) participated in the study.Intervention(s):The first six PHA patients were studied on three occasions to determine whether steroid pretreatment reduced (11)C-metomidate uptake by normal adrenal. Subsequent patients received dexamethasone for 3 d prior to injection of (11)C-metomidate 150-500 MBq.Main Outcome Measure(s):Maximum standardized uptake values (SUV(max)) over regions of interest determined from 35-45 min after injection were measured.Results:Dexamethasone increased tumor to normal adrenal SUV(max) ratio by 25.6 ± 5.0% (P < 0.01). PET-CT visualized subcentimeter adenomas and distinguished hot from cold adenomas within a gland. In 25 patients with PHA and AVS lateralization to the side of an adenoma, SUV(max) over tumor (mean ± sem) of 21.7 ± 1.6 was greater than over normal adrenal, 13.8 ± 0.6 (P = 0.00003); this difference was absent in 10 patients without lateralization on AVS (P = 0.28) and in four of five incidentalomas. On receiver-operator characteristics analysis, an SUV(max) ratio of 1.25:1 provided a specificity of 87% [95% confidence interval (69, 104)] and sensitivity of 76% (59, 93); in tumors with SUV(max) greater than 17, the specificity rose to 100%.Conclusions:(11)C-metomidate PET-CT is a sensitive and specific noninvasive alternative to AVS in the management of PHA.
Authors:
Timothy J Burton; Isla S Mackenzie; Kottekkattu Balan; Brendan Koo; Nick Bird; Dmitri V Soloviev; Elena A B Azizan; Franklin Aigbirhio; Mark Gurnell; Morris J Brown
Related Documents :
22172535 - Whole brain white matter changes revealed by multiple diffusion metrics in multiple scl...
16921255 - The role of the supramammillary commissure in mr localization of the subthalamic nucleus.
15537185 - Stereotactic radiation treatment planning and follow-up studies involving fused multimo...
21785975 - Predictive validity of mri in detecting and following cholesteatoma.
21308835 - Abnormalities of the upper extremities on fetal mri.
17522865 - The intravertebral vacuum phenomen as specific sign of osteonecrosis in vertebral compr...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-23
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  -     ISSN:  1945-7197     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Clinical Pharmacology Unit (T.J.B., I.S.M., E.A.B.A., M.J.B.), Department of Medicine, University of Cambridge, Cambridge CB2 2QQ, United Kingdom; Department of Radiology (K.B., B.K., N.B.), Addenbrooke's Hospital, Cambridge CB2 2QQ, United Kingdom; and Wolfson Brain Imaging Centre (D.V.S., F.A.) and Institute of Metabolic Science (M.G.), Department of Medicine, University of Cambridge, Cambridge CB2 OQQ, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-Term Follow-Up for Mortality and Cancer in a Randomized Placebo-Controlled Trial of Vitamin D3 ...
Next Document:  New Pathogenic Thyrotropin Receptor Mutations Decipher Differentiated Activity Switching at a Conser...